Question 1

What is the catalog number for CA 19-9 (Cancer, Cancer antigen 19-9, CA 199) (MaxLight 750) discontinued?

Accepted Answer

The catalog number for CA 19-9 (Cancer, Cancer antigen 19-9, CA 199) (MaxLight 750) discontinued is 226862-ML750.

Question 2

What sizes are available for CA 19-9 (Cancer, Cancer antigen 19-9, CA 199) (MaxLight 750) discontinued?

Accepted Answer

CA 19-9 (Cancer, Cancer antigen 19-9, CA 199) (MaxLight 750) discontinued is available in the following size(s): 100 µL.

Question 3

Is CA 19-9 (Cancer, Cancer antigen 19-9, CA 199) (MaxLight 750) discontinued in stock?

Accepted Answer

CA 19-9 (Cancer, Cancer antigen 19-9, CA 199) (MaxLight 750) discontinued is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 5

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

Question 6

What is the recommended positive control for this assay?

Accepted Answer

A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.

CA 19-9 (Cancer, Cancer antigen 19-9, CA 199) (MaxLight 750) discontinued

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

Anti-Podoplanin/gp36/PDPN Antibody Picoband®, Dylight594 Conjugate

MyoD1 (Rhabdomyosarcoma Marker) (MYOD1/2075R), CF647 conjugate, 0.1mg/mL

Anti-LY6E/SCA-2 Antibody Picoband®

Anti-FGFR2 Antibody Picoband®

Anti-CLIC1 Antibody Picoband®

CD34 (QBEnd/10 + HPCA1/763), CF594 conjugate, 0.1mg/mL